A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise

Summary

This study is intended to determine the dose response and duration of action of GSK2190915 in mild asthmatic adult subjects who experience exercise-induced bronchoconstriction.

Timeline

Start

2008-12-01

Primary completion

2009-06-01

Completion

2009-07-15

Publications

• Kent SE, Bentley JH, Miller D, Sterling R, Menendez R, Tarpay M, Pearlman DS, Norris V. The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction. Allergy Asthma Proc. 2014 Mar-Apr;35(2):126-33. doi: 10.2500/aap.2014.35.3723.

Drugs

Indications